FKBP9 and cancer: Although the proposed therapeutic overexpression will restore the normal expression of FKBP9 in all three cancer nodules, while upregulating it in “Z”, it would have significant consequences only on “P”, owing to the low FKBP9 GCH scores in the other three regions.